- Home
- MLSS vs TPST Comparison
MLSS vs TPST Comparison
Compare MLSS & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLSS
- TPST
- Stock Information
- Founded
- MLSS 1989
- TPST 2011
- Country
- MLSS United States
- TPST United States
- Employees
- MLSS N/A
- TPST N/A
- Industry
- MLSS Industrial Specialties
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- MLSS Health Care
- TPST Health Care
- Exchange
- MLSS Nasdaq
- TPST Nasdaq
- Market Cap
- MLSS 42.4M
- TPST 45.5M
- IPO Year
- MLSS 1995
- TPST N/A
- Fundamental
- Price
- MLSS $0.43
- TPST $10.47
- Analyst Decision
- MLSS Buy
- TPST Hold
- Analyst Count
- MLSS 1
- TPST 3
- Target Price
- MLSS $1.25
- TPST $30.00
- AVG Volume (30 Days)
- MLSS 184.8K
- TPST 47.8K
- Earning Date
- MLSS 11-13-2025
- TPST 11-11-2025
- Dividend Yield
- MLSS N/A
- TPST N/A
- EPS Growth
- MLSS N/A
- TPST N/A
- EPS
- MLSS N/A
- TPST N/A
- Revenue
- MLSS $9,083,205.00
- TPST N/A
- Revenue This Year
- MLSS $16.06
- TPST N/A
- Revenue Next Year
- MLSS $14.73
- TPST N/A
- P/E Ratio
- MLSS N/A
- TPST N/A
- Revenue Growth
- MLSS 7.84
- TPST N/A
- 52 Week Low
- MLSS $0.38
- TPST $5.35
- 52 Week High
- MLSS $1.39
- TPST $15.73
- Technical
- Relative Strength Index (RSI)
- MLSS 34.39
- TPST 49.96
- Support Level
- MLSS $0.43
- TPST $10.09
- Resistance Level
- MLSS $0.46
- TPST $12.22
- Average True Range (ATR)
- MLSS 0.04
- TPST 0.70
- MACD
- MLSS -0.00
- TPST -0.10
- Stochastic Oscillator
- MLSS 0.69
- TPST 17.40
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.